demonstrated that SULF2 promotes proliferation and metastasis of colorectal cancer by activating the Akt and Erk1/2 signalling pathways; its high expression is associated with malignant clinical features and poor prognosis, and knockdown of SULF2 significantly suppresses tumour growth and invasion. This evidence concerns the gene MAPK3 and colorectal cancer.